2 | 3 | | 1 |
---|
3 | 4 | | Vaccine Amendments |
---|
4 | 5 | | 2025 GENERAL SESSION |
---|
5 | 6 | | STATE OF UTAH |
---|
6 | 7 | | Chief Sponsor: Trevor Lee |
---|
7 | 8 | | Senate Sponsor: Keith Grover |
---|
8 | 9 | | 2 |
---|
9 | 10 | | |
---|
10 | 11 | | 3 |
---|
11 | 12 | | LONG TITLE |
---|
12 | 13 | | 4 |
---|
13 | 14 | | General Description: |
---|
14 | 15 | | 5 |
---|
15 | 16 | | This bill addresses vaccines or vaccine material. |
---|
16 | 17 | | 6 |
---|
17 | 18 | | Highlighted Provisions: |
---|
18 | 19 | | 7 |
---|
19 | 20 | | This bill: |
---|
20 | 21 | | 8 |
---|
21 | 22 | | ▸ defines terms; |
---|
22 | 23 | | 9 |
---|
23 | 24 | | ▸ designates food intended for human consumption that intentionally contains a vaccine or |
---|
24 | 25 | | 10 |
---|
25 | 26 | | vaccine material as a drug; and |
---|
26 | 27 | | 11 |
---|
27 | 28 | | ▸ makes technical amendments. |
---|
28 | 29 | | 12 |
---|
29 | 30 | | Money Appropriated in this Bill: |
---|
30 | 31 | | 13 |
---|
31 | 32 | | None |
---|
32 | 33 | | 14 |
---|
33 | 34 | | Other Special Clauses: |
---|
34 | 35 | | 15 |
---|
35 | 36 | | None |
---|
36 | 37 | | 16 |
---|
37 | 38 | | Utah Code Sections Affected: |
---|
38 | 39 | | 17 |
---|
39 | 40 | | AMENDS: |
---|
40 | 41 | | 18 |
---|
41 | 42 | | 26B-7-108, as renumbered and amended by Laws of Utah 2023, Chapter 308 |
---|
42 | 43 | | 19 |
---|
43 | 44 | | 58-37-2, as last amended by Laws of Utah 2024, Chapter 35 |
---|
44 | 45 | | 20 |
---|
45 | 46 | | ENACTS: |
---|
46 | 47 | | 21 |
---|
47 | 48 | | 4-5-107, Utah Code Annotated 1953 |
---|
48 | 49 | | 22 |
---|
49 | 50 | | |
---|
50 | 51 | | 23 |
---|
51 | 52 | | Be it enacted by the Legislature of the state of Utah: |
---|
52 | 53 | | 24 |
---|
53 | 54 | | Section 1. Section 4-5-107 is enacted to read: |
---|
54 | 55 | | 25 |
---|
55 | 56 | | 4-5-107 . Food containing vaccine. |
---|
56 | 57 | | 26 |
---|
57 | 58 | | (1) As used in this section, "vaccine or vaccine material" means a substance that is: |
---|
58 | 59 | | 27 |
---|
59 | 60 | | (a) intended for use in humans to stimulate the production of antibodies and provide |
---|
60 | 61 | | 28 |
---|
64 | 66 | | 30 |
---|
65 | 67 | | substitute treated to act as an antigen without including the disease; and |
---|
66 | 68 | | 31 |
---|
67 | 69 | | (c) authorized or approved by the United States Food and Drug Administration. |
---|
68 | 70 | | 32 |
---|
69 | 71 | | (2) A food intended for human consumption that intentionally contains a vaccine or vaccine |
---|
70 | 72 | | 33 |
---|
71 | 73 | | material is considered a drug for purposes of this chapter, Section 26B-7-108, and Title |
---|
72 | 74 | | 34 |
---|
73 | 75 | | 58, Chapter 37, Utah Controlled Substances Act. |
---|
74 | 76 | | 35 |
---|
75 | 77 | | Section 2. Section 26B-7-108 is amended to read: |
---|
76 | 78 | | 36 |
---|
77 | 79 | | 26B-7-108 . Rules for sale of drugs, cosmetics, and medical devices. |
---|
78 | 80 | | 37 |
---|
79 | 81 | | (1) The department shall [establish] make rules, in accordance with Title 63G, Chapter |
---|
80 | 82 | | 38 |
---|
81 | 83 | | 3, Utah Administrative Rulemaking Act, and enforce the rules for the sale or distribution |
---|
82 | 84 | | 39 |
---|
83 | 85 | | of human drugs, cosmetics, and medical devices. |
---|
84 | 86 | | 40 |
---|
85 | 87 | | (2) Food intended for human consumption that intentionally contains a vaccine or vaccine |
---|
86 | 88 | | 41 |
---|
87 | 89 | | material is considered a human drug for purposes of this section as provided in Section |
---|
88 | 90 | | 42 |
---|
89 | 91 | | 4-5-107. |
---|
90 | 92 | | 43 |
---|
91 | 93 | | (3) The rules adopted under this section shall be no more stringent than those established by |
---|
92 | 94 | | 44 |
---|
93 | 95 | | federal law. |
---|
94 | 96 | | 45 |
---|
95 | 97 | | Section 3. Section 58-37-2 is amended to read: |
---|
96 | 98 | | 46 |
---|
97 | 99 | | 58-37-2 . Definitions. |
---|
98 | 100 | | 47 |
---|
99 | 101 | | (1) As used in this chapter: |
---|
100 | 102 | | 48 |
---|
101 | 103 | | (a) "Administer" means the direct application of a controlled substance, whether by |
---|
102 | 104 | | 49 |
---|
103 | 105 | | injection, inhalation, ingestion, or any other means, to the body of a patient or |
---|
104 | 106 | | 50 |
---|
105 | 107 | | research subject by: |
---|
106 | 108 | | 51 |
---|
107 | 109 | | (i) a practitioner or, in the practitioner's presence, by the practitioner's authorized |
---|
108 | 110 | | 52 |
---|
109 | 111 | | agent; or |
---|
110 | 112 | | 53 |
---|
111 | 113 | | (ii) the patient or research subject at the direction and in the presence of the |
---|
112 | 114 | | 54 |
---|
113 | 115 | | practitioner. |
---|
114 | 116 | | 55 |
---|
115 | 117 | | (b) "Agent" means an authorized person who acts on behalf of or at the direction of a |
---|
116 | 118 | | 56 |
---|
117 | 119 | | manufacturer, distributor, or practitioner but does not include a motor carrier, public |
---|
118 | 120 | | 57 |
---|
119 | 121 | | warehouseman, or employee of any of them. |
---|
120 | 122 | | 58 |
---|
121 | 123 | | (c) "Consumption" means ingesting or having any measurable amount of a controlled |
---|
122 | 124 | | 59 |
---|
123 | 125 | | substance in a person's body, but this Subsection (1)(c) does not include the |
---|
124 | 126 | | 60 |
---|
125 | 127 | | metabolite of a controlled substance. |
---|
126 | 128 | | 61 |
---|
127 | 129 | | (d) "Continuing criminal enterprise" means any individual, sole proprietorship, |
---|
128 | 130 | | 62 |
---|
129 | 131 | | partnership, corporation, business trust, association, or other legal entity, and any |
---|
133 | 135 | | 64 |
---|
134 | 136 | | includes illicit as well as licit entities created or maintained for the purpose of |
---|
135 | 137 | | 65 |
---|
136 | 138 | | engaging in conduct which constitutes the commission of episodes of activity made |
---|
137 | 139 | | 66 |
---|
138 | 140 | | unlawful by [Chapter 37, Utah Controlled Substances Act] this chapter, Chapter 37a, |
---|
139 | 141 | | 67 |
---|
140 | 142 | | Utah Drug Paraphernalia Act, Chapter 37b, Imitation Controlled Substances Act, |
---|
141 | 143 | | 68 |
---|
142 | 144 | | Chapter 37c, Utah Controlled Substance Precursor Act, or Chapter 37d, Clandestine |
---|
143 | 145 | | 69 |
---|
144 | 146 | | Drug Lab Act, which episodes are not isolated, but have the same or similar |
---|
145 | 147 | | 70 |
---|
146 | 148 | | purposes, results, participants, victims, methods of commission, or otherwise are |
---|
147 | 149 | | 71 |
---|
148 | 150 | | interrelated by distinguishing characteristics. Taken together, the episodes shall |
---|
149 | 151 | | 72 |
---|
150 | 152 | | demonstrate continuing unlawful conduct and be related either to each other or to the |
---|
151 | 153 | | 73 |
---|
152 | 154 | | enterprise. |
---|
153 | 155 | | 74 |
---|
154 | 156 | | (e) "Control" means to add, remove, or change the placement of a drug, substance, or |
---|
155 | 157 | | 75 |
---|
156 | 158 | | immediate precursor under Section 58-37-3. |
---|
157 | 159 | | 76 |
---|
158 | 160 | | (f)(i) "Controlled substance" means a drug or substance: |
---|
159 | 161 | | 77 |
---|
160 | 162 | | (A) included in Schedules I, II, III, IV, or V of Section 58-37-4; |
---|
161 | 163 | | 78 |
---|
162 | 164 | | (B) included in Schedules I, II, III, IV, or V of the federal Controlled Substances |
---|
163 | 165 | | 79 |
---|
164 | 166 | | Act, Title II, P.L. 91-513; |
---|
165 | 167 | | 80 |
---|
166 | 168 | | (C) that is a controlled substance analog; or |
---|
167 | 169 | | 81 |
---|
168 | 170 | | (D) listed in Section 58-37-4.2. |
---|
169 | 171 | | 82 |
---|
170 | 172 | | (ii) "Controlled substance" does not include: |
---|
171 | 173 | | 83 |
---|
172 | 174 | | (A) distilled spirits, wine, or malt beverages, as those terms are defined in Title |
---|
173 | 175 | | 84 |
---|
174 | 176 | | 32B, Alcoholic Beverage Control Act; |
---|
175 | 177 | | 85 |
---|
176 | 178 | | (B) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, |
---|
177 | 179 | | 86 |
---|
178 | 180 | | or prevention of disease in human or other animals, which contains ephedrine, |
---|
179 | 181 | | 87 |
---|
180 | 182 | | pseudoephedrine, norpseudoephedrine, or phenylpropanolamine if the drug is |
---|
181 | 183 | | 88 |
---|
182 | 184 | | lawfully purchased, sold, transferred, or furnished as an over-the-counter |
---|
183 | 185 | | 89 |
---|
184 | 186 | | medication without prescription; or |
---|
185 | 187 | | 90 |
---|
186 | 188 | | (C) dietary supplements, vitamins, minerals, herbs, or other similar substances |
---|
187 | 189 | | 91 |
---|
188 | 190 | | including concentrates or extracts, which: |
---|
189 | 191 | | 92 |
---|
190 | 192 | | (I) are not otherwise regulated by law; and |
---|
191 | 193 | | 93 |
---|
192 | 194 | | (II) may contain naturally occurring amounts of chemical or substances listed |
---|
193 | 195 | | 94 |
---|
194 | 196 | | in this chapter, or in rules adopted pursuant to Title 63G, Chapter 3, Utah |
---|
195 | 197 | | 95 |
---|
196 | 198 | | Administrative Rulemaking Act. |
---|
197 | 199 | | 96 |
---|
198 | 200 | | (g)(i) "Controlled substance analog" means: |
---|
202 | 204 | | 98 |
---|
203 | 205 | | chemical structure of a controlled substance listed in Schedules I and II of |
---|
204 | 206 | | 99 |
---|
205 | 207 | | Section 58-37-4, a substance listed in Section 58-37-4.2, or in Schedules I and |
---|
206 | 208 | | 100 |
---|
207 | 209 | | II of the federal Controlled Substances Act, Title II, P.L. 91-513; |
---|
208 | 210 | | 101 |
---|
209 | 211 | | (B) a substance [which] that has a stimulant, depressant, or hallucinogenic effect |
---|
210 | 212 | | 102 |
---|
211 | 213 | | on the central nervous system substantially similar to the stimulant, depressant, |
---|
212 | 214 | | 103 |
---|
213 | 215 | | or hallucinogenic effect on the central nervous system of controlled substances |
---|
214 | 216 | | 104 |
---|
215 | 217 | | listed in Schedules I and II of Section 58-37-4, substances listed in Section |
---|
216 | 218 | | 105 |
---|
217 | 219 | | 58-37-4.2, or substances listed in Schedules I and II of the federal Controlled |
---|
218 | 220 | | 106 |
---|
219 | 221 | | Substances Act, Title II, P.L. 91-513; or |
---|
220 | 222 | | 107 |
---|
221 | 223 | | (C) A substance [which] that, with respect to a particular individual, is represented |
---|
222 | 224 | | 108 |
---|
223 | 225 | | or intended to have a stimulant, depressant, or hallucinogenic effect on the |
---|
224 | 226 | | 109 |
---|
225 | 227 | | central nervous system substantially similar to the stimulant, depressant, or |
---|
226 | 228 | | 110 |
---|
227 | 229 | | hallucinogenic effect on the central nervous system of controlled substances |
---|
228 | 230 | | 111 |
---|
229 | 231 | | listed in Schedules I and II of Section 58-37-4, substances listed in Section |
---|
230 | 232 | | 112 |
---|
231 | 233 | | 58-37-4.2, or substances listed in Schedules I and II of the federal Controlled |
---|
232 | 234 | | 113 |
---|
233 | 235 | | Substances Act, Title II, P.L. 91-513. |
---|
234 | 236 | | 114 |
---|
235 | 237 | | (ii) "Controlled substance analog" does not include: |
---|
236 | 238 | | 115 |
---|
237 | 239 | | (A) a controlled substance currently scheduled in Schedules I through V of |
---|
238 | 240 | | 116 |
---|
239 | 241 | | Section 58-37-4; |
---|
240 | 242 | | 117 |
---|
241 | 243 | | (B) a substance for which there is an approved new drug application; |
---|
242 | 244 | | 118 |
---|
243 | 245 | | (C) a substance with respect to which an exemption is in effect for investigational |
---|
244 | 246 | | 119 |
---|
245 | 247 | | use by a particular person under Section 505 of the Food, Drug, and Cosmetic |
---|
246 | 248 | | 120 |
---|
247 | 249 | | Act, 21 U.S.C. 355, to the extent the conduct with respect to the substance is |
---|
248 | 250 | | 121 |
---|
249 | 251 | | permitted by the exemption; |
---|
250 | 252 | | 122 |
---|
251 | 253 | | (D) any substance to the extent not intended for human consumption before an |
---|
252 | 254 | | 123 |
---|
253 | 255 | | exemption takes effect with respect to the substance; |
---|
254 | 256 | | 124 |
---|
255 | 257 | | (E) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, |
---|
256 | 258 | | 125 |
---|
257 | 259 | | or prevention of disease in man or other animals, which contains ephedrine, |
---|
258 | 260 | | 126 |
---|
259 | 261 | | pseudoephedrine, norpseudoephedrine, or phenylpropanolamine if the drug is |
---|
260 | 262 | | 127 |
---|
261 | 263 | | lawfully purchased, sold, transferred, or furnished as an over-the-counter |
---|
262 | 264 | | 128 |
---|
263 | 265 | | medication without prescription; or |
---|
264 | 266 | | 129 |
---|
265 | 267 | | (F) dietary supplements, vitamins, minerals, herbs, or other similar substances |
---|
266 | 268 | | 130 |
---|
267 | 269 | | including concentrates or extracts, which are not otherwise regulated by law, |
---|
271 | 273 | | 132 |
---|
272 | 274 | | listed in this chapter, or in rules adopted pursuant to Title 63G, Chapter 3, Utah |
---|
273 | 275 | | 133 |
---|
274 | 276 | | Administrative Rulemaking Act. |
---|
275 | 277 | | 134 |
---|
276 | 278 | | (h)(i) "Conviction" means a determination of guilt by verdict, whether jury or bench, |
---|
277 | 279 | | 135 |
---|
278 | 280 | | or plea, whether guilty or no contest, for any offense proscribed by: |
---|
279 | 281 | | 136 |
---|
280 | 282 | | (A) [Chapter 37, Utah Controlled Substances Act] this chapter; |
---|
281 | 283 | | 137 |
---|
282 | 284 | | (B) Chapter 37a, Utah Drug Paraphernalia Act; |
---|
283 | 285 | | 138 |
---|
284 | 286 | | (C) Chapter 37b, Imitation Controlled Substances Act; |
---|
285 | 287 | | 139 |
---|
286 | 288 | | (D) Chapter 37c, Utah Controlled Substance Precursor Act; or |
---|
287 | 289 | | 140 |
---|
288 | 290 | | (E) Chapter 37d, Clandestine Drug Lab Act; or |
---|
289 | 291 | | 141 |
---|
290 | 292 | | (ii) for any offense under the laws of the United States and any other state which, if |
---|
291 | 293 | | 142 |
---|
292 | 294 | | committed in this state, would be an offense under: |
---|
293 | 295 | | 143 |
---|
294 | 296 | | (A) [Chapter 37, Utah Controlled Substances Act] this chapter; |
---|
295 | 297 | | 144 |
---|
296 | 298 | | (B) Chapter 37a, Utah Drug Paraphernalia Act; |
---|
297 | 299 | | 145 |
---|
298 | 300 | | (C) Chapter 37b, Imitation Controlled Substances Act; |
---|
299 | 301 | | 146 |
---|
300 | 302 | | (D) Chapter 37c, Utah Controlled Substance Precursor Act; or |
---|
301 | 303 | | 147 |
---|
302 | 304 | | (E) Chapter 37d, Clandestine Drug Lab Act. |
---|
303 | 305 | | 148 |
---|
304 | 306 | | (i) "Counterfeit substance" means: |
---|
305 | 307 | | 149 |
---|
306 | 308 | | (i) any controlled substance or container or labeling of any controlled substance that: |
---|
307 | 309 | | 150 |
---|
308 | 310 | | (A) without authorization bears the trademark, trade name, or other identifying |
---|
309 | 311 | | 151 |
---|
310 | 312 | | mark, imprint, number, device, or any likeness of them, of a manufacturer, |
---|
311 | 313 | | 152 |
---|
312 | 314 | | distributor, or dispenser other than the person or persons who in fact |
---|
313 | 315 | | 153 |
---|
314 | 316 | | manufactured, distributed, or dispensed the substance which falsely purports to |
---|
315 | 317 | | 154 |
---|
316 | 318 | | be a controlled substance distributed by any other manufacturer, distributor, or |
---|
317 | 319 | | 155 |
---|
318 | 320 | | dispenser; and |
---|
319 | 321 | | 156 |
---|
320 | 322 | | (B) a reasonable person would believe to be a controlled substance distributed by |
---|
321 | 323 | | 157 |
---|
322 | 324 | | an authorized manufacturer, distributor, or dispenser based on the appearance |
---|
323 | 325 | | 158 |
---|
324 | 326 | | of the substance as described under Subsection (1)(i)(i)(A) or the appearance of |
---|
325 | 327 | | 159 |
---|
326 | 328 | | the container of that controlled substance; or |
---|
327 | 329 | | 160 |
---|
328 | 330 | | (ii) any substance other than under Subsection (1)(i)(i) that: |
---|
329 | 331 | | 161 |
---|
330 | 332 | | (A) is falsely represented to be any legally or illegally manufactured controlled |
---|
331 | 333 | | 162 |
---|
332 | 334 | | substance; and |
---|
333 | 335 | | 163 |
---|
334 | 336 | | (B) a reasonable person would believe to be a legal or illegal controlled substance. |
---|
335 | 337 | | 164 |
---|
336 | 338 | | (j) "Deliver" or "delivery" means the actual, constructive, or attempted transfer of a |
---|
340 | 342 | | 166 |
---|
341 | 343 | | (k) "Department" means the Department of Commerce. |
---|
342 | 344 | | 167 |
---|
343 | 345 | | (l) "Depressant or stimulant substance" means: |
---|
344 | 346 | | 168 |
---|
345 | 347 | | (i) a drug which contains any quantity of barbituric acid or any of the salts of |
---|
346 | 348 | | 169 |
---|
347 | 349 | | barbituric acid; |
---|
348 | 350 | | 170 |
---|
349 | 351 | | (ii) a drug which contains any quantity of: |
---|
350 | 352 | | 171 |
---|
351 | 353 | | (A) amphetamine or any of its optical isomers; |
---|
352 | 354 | | 172 |
---|
353 | 355 | | (B) any salt of amphetamine or any salt of an optical isomer of amphetamine; or |
---|
354 | 356 | | 173 |
---|
355 | 357 | | (C) any substance which the Secretary of Health and Human Services or the |
---|
356 | 358 | | 174 |
---|
357 | 359 | | Attorney General of the United States after investigation has found and by |
---|
358 | 360 | | 175 |
---|
359 | 361 | | regulation designated habit-forming because of its stimulant effect on the |
---|
360 | 362 | | 176 |
---|
361 | 363 | | central nervous system; |
---|
362 | 364 | | 177 |
---|
363 | 365 | | (iii) lysergic acid diethylamide; or |
---|
364 | 366 | | 178 |
---|
365 | 367 | | (iv) any drug which contains any quantity of a substance which the Secretary of |
---|
366 | 368 | | 179 |
---|
367 | 369 | | Health and Human Services or the Attorney General of the United States after |
---|
368 | 370 | | 180 |
---|
369 | 371 | | investigation has found to have, and by regulation designated as having, a |
---|
370 | 372 | | 181 |
---|
371 | 373 | | potential for abuse because of its depressant or stimulant effect on the central |
---|
372 | 374 | | 182 |
---|
373 | 375 | | nervous system or its hallucinogenic effect. |
---|
374 | 376 | | 183 |
---|
375 | 377 | | (m) "Dispense" means the delivery of a controlled substance by a pharmacist to an |
---|
376 | 378 | | 184 |
---|
377 | 379 | | ultimate user pursuant to the lawful order or prescription of a practitioner, and |
---|
378 | 380 | | 185 |
---|
379 | 381 | | includes distributing to, leaving with, giving away, or disposing of that substance as |
---|
380 | 382 | | 186 |
---|
381 | 383 | | well as the packaging, labeling, or compounding necessary to prepare the substance |
---|
382 | 384 | | 187 |
---|
383 | 385 | | for delivery. |
---|
384 | 386 | | 188 |
---|
385 | 387 | | (n) "Dispenser" means a pharmacist who dispenses a controlled substance. |
---|
386 | 388 | | 189 |
---|
387 | 389 | | (o) "Distribute" means to deliver other than by administering or dispensing a controlled |
---|
388 | 390 | | 190 |
---|
389 | 391 | | substance or a listed chemical. |
---|
390 | 392 | | 191 |
---|
391 | 393 | | (p) "Distributor" means a person who distributes controlled substances. |
---|
392 | 394 | | 192 |
---|
393 | 395 | | (q) "Division" means the Division of Professional Licensing created in Section 58-1-103. |
---|
394 | 396 | | 193 |
---|
395 | 397 | | (r)(i) "Drug" means: |
---|
396 | 398 | | 194 |
---|
397 | 399 | | (A) a substance recognized in the official United States Pharmacopoeia, Official |
---|
398 | 400 | | 195 |
---|
399 | 401 | | Homeopathic Pharmacopoeia of the United States, or Official National |
---|
400 | 402 | | 196 |
---|
401 | 403 | | Formulary, or any supplement to any of them, intended for use in the |
---|
402 | 404 | | 197 |
---|
403 | 405 | | diagnosis, cure, mitigation, treatment, or prevention of disease in humans or |
---|
404 | 406 | | 198 |
---|
405 | 407 | | animals; |
---|
409 | 411 | | 200 |
---|
410 | 412 | | dispensed by prescription only or is restricted to administration by practitioners |
---|
411 | 413 | | 201 |
---|
412 | 414 | | only; |
---|
413 | 415 | | 202 |
---|
414 | 416 | | (C) a substance other than food intended to affect the structure or any function of |
---|
415 | 417 | | 203 |
---|
416 | 418 | | the body of humans or other animals; and |
---|
417 | 419 | | 204 |
---|
418 | 420 | | (D) substances intended for use as a component of any substance specified in |
---|
419 | 421 | | 205 |
---|
420 | 422 | | Subsections (1)(r)(i)(A), (B), and (C). |
---|
421 | 423 | | 206 |
---|
422 | 424 | | (ii) "Drug" does not include dietary supplements. |
---|
423 | 425 | | 207 |
---|
424 | 426 | | (iii) "Drug" includes a food intended for human consumption that intentionally |
---|
425 | 427 | | 208 |
---|
426 | 428 | | contains a vaccine or vaccine material as provided in Section 4-5-107. |
---|
427 | 429 | | 209 |
---|
428 | 430 | | (s) "Drug dependent person" means any individual who unlawfully and habitually uses |
---|
429 | 431 | | 210 |
---|
430 | 432 | | any controlled substance to endanger the public morals, health, safety, or welfare, or |
---|
431 | 433 | | 211 |
---|
432 | 434 | | who is so dependent upon the use of controlled substances as to have lost the power |
---|
433 | 435 | | 212 |
---|
434 | 436 | | of self-control with reference to the individual's dependency. |
---|
435 | 437 | | 213 |
---|
436 | 438 | | (t)(i) "Food" means: |
---|
437 | 439 | | 214 |
---|
438 | 440 | | [(i)] (A) any nutrient or substance of plant, mineral, or animal origin other than a |
---|
439 | 441 | | 215 |
---|
440 | 442 | | drug as specified in this chapter, and normally ingested by human beings; and |
---|
441 | 443 | | 216 |
---|
442 | 444 | | [(ii)] (B) foods for special dietary uses as exist by reason of a physical, |
---|
443 | 445 | | 217 |
---|
444 | 446 | | physiological, pathological, or other condition including[ but not limited to] the |
---|
445 | 447 | | 218 |
---|
446 | 448 | | conditions of disease, convalescence, pregnancy, lactation, allergy, |
---|
447 | 449 | | 219 |
---|
448 | 450 | | hypersensitivity to food, underweight, and overweight; uses for supplying a |
---|
449 | 451 | | 220 |
---|
450 | 452 | | particular dietary need which exist by reason of age including[ but not limited |
---|
451 | 453 | | 221 |
---|
452 | 454 | | to] the ages of infancy and childbirth, and also uses for supplementing and for |
---|
453 | 455 | | 222 |
---|
454 | 456 | | fortifying the ordinary or unusual diet with any vitamin, mineral, or other |
---|
455 | 457 | | 223 |
---|
456 | 458 | | dietary property for use of a food. |
---|
457 | 459 | | 224 |
---|
458 | 460 | | (ii) Any particular use of a food is a special dietary use regardless of the nutritional |
---|
459 | 461 | | 225 |
---|
460 | 462 | | purposes. |
---|
461 | 463 | | 226 |
---|
462 | 464 | | (u) "Immediate precursor" means a substance which the Attorney General of the United |
---|
463 | 465 | | 227 |
---|
464 | 466 | | States has found to be, and by regulation designated as being, the principal compound |
---|
465 | 467 | | 228 |
---|
466 | 468 | | used or produced primarily for use in the manufacture of a controlled substance, or |
---|
467 | 469 | | 229 |
---|
468 | 470 | | which is an immediate chemical intermediary used or likely to be used in the |
---|
469 | 471 | | 230 |
---|
470 | 472 | | manufacture of a controlled substance, the control of which is necessary to prevent, |
---|
471 | 473 | | 231 |
---|
472 | 474 | | curtail, or limit the manufacture of the controlled substance. |
---|
473 | 475 | | 232 |
---|
474 | 476 | | (v) "Indian" means a member of an Indian tribe. |
---|
478 | 480 | | 234 |
---|
479 | 481 | | (i) the origin and interpretation of which is from within a traditional Indian culture or |
---|
480 | 482 | | 235 |
---|
481 | 483 | | community; and |
---|
482 | 484 | | 236 |
---|
483 | 485 | | (ii) [which] that is practiced by Indians. |
---|
484 | 486 | | 237 |
---|
485 | 487 | | (x) "Indian tribe" means any tribe, band, nation, pueblo, or other organized group or |
---|
486 | 488 | | 238 |
---|
487 | 489 | | community of Indians, including any Alaska Native village, which is legally |
---|
488 | 490 | | 239 |
---|
489 | 491 | | recognized as eligible for and is consistent with the special programs, services, and |
---|
490 | 492 | | 240 |
---|
491 | 493 | | entitlements provided by the United States to Indians because of their status as |
---|
492 | 494 | | 241 |
---|
493 | 495 | | Indians. |
---|
494 | 496 | | 242 |
---|
495 | 497 | | (y) "Manufacture" means the production, preparation, propagation, compounding, or |
---|
496 | 498 | | 243 |
---|
497 | 499 | | processing of a controlled substance, either directly or indirectly by extraction from |
---|
498 | 500 | | 244 |
---|
499 | 501 | | substances of natural origin, or independently by means of chemical synthesis or by a |
---|
500 | 502 | | 245 |
---|
501 | 503 | | combination of extraction and chemical synthesis. |
---|
502 | 504 | | 246 |
---|
503 | 505 | | (z) "Manufacturer" includes any person who packages, repackages, or labels any |
---|
504 | 506 | | 247 |
---|
505 | 507 | | container of any controlled substance, except pharmacists who dispense or compound |
---|
506 | 508 | | 248 |
---|
507 | 509 | | prescription orders for delivery to the ultimate consumer. |
---|
508 | 510 | | 249 |
---|
509 | 511 | | (aa)(i) "Marijuana" means all species of the genus cannabis and all parts of the genus, |
---|
510 | 512 | | 250 |
---|
511 | 513 | | whether growing or not, including: |
---|
512 | 514 | | 251 |
---|
513 | 515 | | (A) seeds; |
---|
514 | 516 | | 252 |
---|
515 | 517 | | (B) resin extracted from any part of the plant, including the resin extracted from |
---|
516 | 518 | | 253 |
---|
517 | 519 | | the mature stalks; |
---|
518 | 520 | | 254 |
---|
519 | 521 | | (C) every compound, manufacture, salt, derivative, mixture, or preparation of the |
---|
520 | 522 | | 255 |
---|
521 | 523 | | plant, seeds, or resin; |
---|
522 | 524 | | 256 |
---|
523 | 525 | | (D) any synthetic equivalents of the substances contained in the plant cannabis |
---|
524 | 526 | | 257 |
---|
525 | 527 | | sativa or any other species of the genus cannabis which are chemically |
---|
526 | 528 | | 258 |
---|
527 | 529 | | indistinguishable and pharmacologically active; and |
---|
528 | 530 | | 259 |
---|
529 | 531 | | (E) any component part or cannabinoid extracted or isolated from the plant, |
---|
530 | 532 | | 260 |
---|
531 | 533 | | including extracted or isolated tetrahydrocannabinols. |
---|
532 | 534 | | 261 |
---|
533 | 535 | | (ii) "Marijuana" does not include: |
---|
534 | 536 | | 262 |
---|
535 | 537 | | (A) the mature stalks of the plant; |
---|
536 | 538 | | 263 |
---|
537 | 539 | | (B) fiber produced from the stalks; |
---|
538 | 540 | | 264 |
---|
539 | 541 | | (C) oil or cake made from the seeds of the plant; |
---|
540 | 542 | | 265 |
---|
541 | 543 | | (D) except as provided in Subsection (1)(aa)(i), any other compound, |
---|
542 | 544 | | 266 |
---|
543 | 545 | | manufacture, salt, derivative, mixture, or preparation of the mature stalks, |
---|
547 | 549 | | 268 |
---|
548 | 550 | | (E) the sterilized seed of the plant which is incapable of germination; |
---|
549 | 551 | | 269 |
---|
550 | 552 | | (F) any compound, mixture, or preparation approved by the federal Food and |
---|
551 | 553 | | 270 |
---|
552 | 554 | | Drug Administration under the federal Food, Drug, and Cosmetic Act, 21 |
---|
553 | 555 | | 271 |
---|
554 | 556 | | U.S.C. Sec. 301 et seq. that is not listed in a schedule of controlled substances |
---|
555 | 557 | | 272 |
---|
556 | 558 | | in Section 58-37-4 or in the federal Controlled Substances Act, Title II, P.L. |
---|
557 | 559 | | 273 |
---|
558 | 560 | | 91-513; or |
---|
559 | 561 | | 274 |
---|
560 | 562 | | (G) transportable industrial hemp concentrate as that term is defined in Section |
---|
561 | 563 | | 275 |
---|
562 | 564 | | 4-41-102. |
---|
563 | 565 | | 276 |
---|
564 | 566 | | (bb) "Money" means officially issued coin and currency of the United States or any |
---|
565 | 567 | | 277 |
---|
566 | 568 | | foreign country. |
---|
567 | 569 | | 278 |
---|
568 | 570 | | (cc) "Narcotic drug" means any of the following, whether produced directly or indirectly |
---|
569 | 571 | | 279 |
---|
570 | 572 | | by extraction from substances of vegetable origin, or independently by means of |
---|
571 | 573 | | 280 |
---|
572 | 574 | | chemical synthesis, or by a combination of extraction and chemical synthesis: |
---|
573 | 575 | | 281 |
---|
574 | 576 | | (i) opium, coca leaves, and opiates; |
---|
575 | 577 | | 282 |
---|
576 | 578 | | (ii) a compound, manufacture, salt, derivative, or preparation of opium, coca leaves, |
---|
577 | 579 | | 283 |
---|
578 | 580 | | or opiates; |
---|
579 | 581 | | 284 |
---|
580 | 582 | | (iii) opium poppy and poppy straw; or |
---|
581 | 583 | | 285 |
---|
582 | 584 | | (iv) a substance, and any compound, manufacture, salt, derivative, or preparation of |
---|
583 | 585 | | 286 |
---|
584 | 586 | | the substance, which is chemically identical with any of the substances referred to |
---|
585 | 587 | | 287 |
---|
586 | 588 | | in Subsection (1)(cc)(i), (ii), or (iii), except narcotic drug does not include |
---|
587 | 589 | | 288 |
---|
588 | 590 | | decocainized coca leaves or extracts of coca leaves which do not contain cocaine |
---|
589 | 591 | | 289 |
---|
590 | 592 | | or ecgonine. |
---|
591 | 593 | | 290 |
---|
592 | 594 | | (dd) "Negotiable instrument" means documents, containing an unconditional promise to |
---|
593 | 595 | | 291 |
---|
594 | 596 | | pay a sum of money, which are legally transferable to another party by endorsement |
---|
595 | 597 | | 292 |
---|
596 | 598 | | or delivery. |
---|
597 | 599 | | 293 |
---|
598 | 600 | | (ee) "Opiate" means any drug or other substance having an addiction-forming or |
---|
599 | 601 | | 294 |
---|
600 | 602 | | addiction-sustaining liability similar to morphine or being capable of conversion into |
---|
601 | 603 | | 295 |
---|
602 | 604 | | a drug having addiction-forming or addiction-sustaining liability. |
---|
603 | 605 | | 296 |
---|
604 | 606 | | (ff) "Opium poppy" means the plant of the species papaver somniferum L., except the |
---|
605 | 607 | | 297 |
---|
606 | 608 | | seeds of the plant. |
---|
607 | 609 | | 298 |
---|
608 | 610 | | (gg) "Person" means any corporation, association, partnership, trust, other institution or |
---|
609 | 611 | | 299 |
---|
610 | 612 | | entity or one or more individuals. |
---|
611 | 613 | | 300 |
---|
612 | 614 | | (hh) "Poppy straw" means all parts, except the seeds, of the opium poppy, after mowing. |
---|
616 | 618 | | 302 |
---|
617 | 619 | | holding, retaining, belonging, maintaining, or the application, inhalation, swallowing, |
---|
618 | 620 | | 303 |
---|
619 | 621 | | injection, or consumption, as distinguished from distribution, of controlled |
---|
620 | 622 | | 304 |
---|
621 | 623 | | substances and includes individual, joint, or group possession or use of controlled |
---|
622 | 624 | | 305 |
---|
623 | 625 | | substances. For a person to be a possessor or user of a controlled substance, it is not |
---|
624 | 626 | | 306 |
---|
625 | 627 | | required that the person be shown to have individually possessed, used, or controlled |
---|
626 | 628 | | 307 |
---|
627 | 629 | | the substance, but it is sufficient if it is shown that the person jointly participated with |
---|
628 | 630 | | 308 |
---|
629 | 631 | | one or more persons in the use, possession, or control of any substances with |
---|
630 | 632 | | 309 |
---|
631 | 633 | | knowledge that the activity was occurring, or the controlled substance is found in a |
---|
632 | 634 | | 310 |
---|
633 | 635 | | place or under circumstances indicating that the person had the ability and the intent |
---|
634 | 636 | | 311 |
---|
635 | 637 | | to exercise dominion and control over [it] the controlled substance. |
---|
636 | 638 | | 312 |
---|
637 | 639 | | (jj) "Practitioner" means a physician, dentist, naturopathic physician, veterinarian, |
---|
638 | 640 | | 313 |
---|
639 | 641 | | pharmacist, scientific investigator, pharmacy, hospital, or other person licensed, |
---|
640 | 642 | | 314 |
---|
641 | 643 | | registered, or otherwise permitted to distribute, dispense, conduct research with |
---|
642 | 644 | | 315 |
---|
643 | 645 | | respect to, administer, or use in teaching or chemical analysis a controlled substance |
---|
644 | 646 | | 316 |
---|
645 | 647 | | in the course of professional practice or research in this state. |
---|
646 | 648 | | 317 |
---|
647 | 649 | | (kk) "Prescribe" means to issue a prescription: |
---|
648 | 650 | | 318 |
---|
649 | 651 | | (i) orally or in writing; or |
---|
650 | 652 | | 319 |
---|
651 | 653 | | (ii) by telephone, facsimile transmission, computer, or other electronic means of |
---|
652 | 654 | | 320 |
---|
653 | 655 | | communication as defined by division rule. |
---|
654 | 656 | | 321 |
---|
655 | 657 | | (ll) "Prescription" means an order issued: |
---|
656 | 658 | | 322 |
---|
657 | 659 | | (i) by a licensed practitioner, in the course of that practitioner's professional practice |
---|
658 | 660 | | 323 |
---|
659 | 661 | | or by collaborative pharmacy practice agreement; and |
---|
660 | 662 | | 324 |
---|
661 | 663 | | (ii) for a controlled substance or other prescription drug or device for use by a patient |
---|
662 | 664 | | 325 |
---|
663 | 665 | | or an animal. |
---|
664 | 666 | | 326 |
---|
665 | 667 | | (mm) "Production" means the manufacture, planting, cultivation, growing, or harvesting |
---|
666 | 668 | | 327 |
---|
667 | 669 | | of a controlled substance. |
---|
668 | 670 | | 328 |
---|
669 | 671 | | (nn) "Securities" means any stocks, bonds, notes, or other evidences of debt or of |
---|
670 | 672 | | 329 |
---|
671 | 673 | | property. |
---|
672 | 674 | | 330 |
---|
673 | 675 | | (oo) "State" means the state of Utah. |
---|
674 | 676 | | 331 |
---|
675 | 677 | | (pp) "Ultimate user" means any person who lawfully possesses a controlled substance |
---|
676 | 678 | | 332 |
---|
677 | 679 | | for the person's own use, for the use of a member of the person's household, or for |
---|
678 | 680 | | 333 |
---|
679 | 681 | | administration to an animal owned by the person or a member of the person's |
---|
680 | 682 | | 334 |
---|
681 | 683 | | household. |
---|